Kezar Life Sciences (KZR) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to -$90.2 million.
- Kezar Life Sciences' Enterprise Value rose 3920.26% to -$90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$90.2 million, marking a year-over-year increase of 3920.26%. This contributed to the annual value of -$132.2 million for FY2024, which is 3432.8% up from last year.
- According to the latest figures from Q3 2025, Kezar Life Sciences' Enterprise Value is -$90.2 million, which was up 3920.26% from -$100.8 million recorded in Q2 2025.
- Kezar Life Sciences' 5-year Enterprise Value high stood at -$90.2 million for Q3 2025, and its period low was -$306.8 million during Q2 2022.
- For the 5-year period, Kezar Life Sciences' Enterprise Value averaged around -$187.4 million, with its median value being -$179.8 million (2024).
- In the last 5 years, Kezar Life Sciences' Enterprise Value crashed by 14046.49% in 2022 and then soared by 3920.26% in 2025.
- Quarter analysis of 5 years shows Kezar Life Sciences' Enterprise Value stood at -$208.4 million in 2021, then plummeted by 32.74% to -$276.6 million in 2022, then grew by 27.19% to -$201.4 million in 2023, then surged by 34.33% to -$132.2 million in 2024, then surged by 31.78% to -$90.2 million in 2025.
- Its Enterprise Value was -$90.2 million in Q3 2025, compared to -$100.8 million in Q2 2025 and -$114.4 million in Q1 2025.